The Full Story in Plain English
What the Study Found (In Plain English)
Why This Matters to You
When you or someone you love is weighing a health decision, medical journals can feel like they are written in a secret code. Yet buried inside those dense reports are practical answers that can help you feel better, avoid unnecessary side effects, and ask smarter questions at your next checkup. That is why a meta-analysis published in Balkan medical journal caught our clinical team's attention.
What the Researchers Looked At
In this study, researchers set out to answer a straightforward question: risk of venous thromboembolism with statins: evidence gathered via a network meta-analysis. To get reliable answers, the team evaluated 137,940 real-world participants using a meta-analysis design—one of the most trusted ways doctors test whether a treatment truly works or is just a fluke.
What the Study Found in Plain English
Published in Balkan medical journal (2023), this meta-analysis evaluating 137,940 human participants investigated: Anticoagulants are the mainstay of treatment for venous thromboembolism (VTE). Key clinical takeaway: Rosuvastatin is significantly reduces the risk of VTE when compared with a placebo, other statin subtypes, and fibrate. Furthermore, fenofibrate increased the VTE risk when compared with a placebo and statins
The Catch: What to Keep in Mind
Even strong medical studies have limits. Every person's body processes medicines and lifestyle changes differently based on age, genetics, kidney and liver health, and other prescriptions in their cabinet. What worked on average in a research setting may need a tailored dose—or a different option altogether—for you.
Bottom Line: Your Next Step
Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me—and is there anything we should adjust?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Published in Balkan medical journal (2023-09-11) • Study Design: Meta-Analysis • Participants: N = 137,940 • Biostatistical Rigor Score: 99/100. Key Finding: Published in Balkan medical journal (2023), this meta-analysis evaluating 137,940 human participants investigated: Anticoagulants are the mainstay of treatment for venous thromboembolism (VTE).
Study Limitations & Caveats Before You Act
While this meta-analysis scored 99/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.
Formal Peer-Reviewed Study Reference
“Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis”
Published in Balkan medical journal (2023-09-11) • PMID/ID: 37519020